User:PamCowart/sandbox

Jay S. Yadav, M.D., F.A.A.C.
Jay S. Yadav (29 October 1959) is an interventional cardiologist, neurologist, scientist and serial entrepreneur.

His best-known discoveries include Angioguard in 19XX, the first embolic protection device shown in clinical testing to achieve a relative stroke reduction of 70% during carotid stenting procedures. SMART therapeutics in XXX the first neuroform microdelivery self-expanding technology for intracranial therapies. CardioMEMS in 2012 the first and only FDA-approved heart failure monitoring system proven to significantly reduce heart failure hospital admissions and improve quality  of life in NYHA class III patients.  Molybdenum-Rhenium  (MoRe) alloy the first rhenium-based alloy to be approved for use in medical  devices in the last 40 years.

Early life and education
Born on 29 October 1959 in XXX, India, Jay is the first of three children of [Father’s name- DOB/DOD] and [Mother’s name- DOB].

Dr. Yadav attended Yale University in 1979 receiving a BS in Molecular Biophysics and Biochemistry then went to medical school at the West Virginia University in 1983 with an internship in internal medicine at University of California-Irvine and residency in neurology at Duke University from 1987-1988. In 1989 he underwent a neuroimaging fellowship at the Dent Neurological Institute in Buffalo, New York. In 1996 he underwent a cardiology and interventional cardiology fellowship at the University of Alabama at Birmingham.

College

1979- Yale University, New Haven, Conn; B.S. Molecular Biophysics & Biochemistry

Medical School

1983- West Virginia University Medical School, Morgantown, WV; Medical Degree

Internship

1984- Univ. of California-Irvine, Irvine, CA; Internal Medicine

Residencies

1987- Duke University Medical Center, Durham, North Carolina; Internal Medicine and Neurology

Chief Residency

1988- Duke University Medical Center, Durham, North Carolina; Neurology

Fellowships

1989- Dent Neurological Institute, Buffalo, New York; Neuroimaging

1996- University of Alabama at Birmingham, Birmingham, Alabama; Cardiology and Interventional Cardiology

Research
·      Executive Committee, Sirolimus – SMART Stent SFA Trial JNJ

·      Chairman, Steering Committee, SAPPHIRE: Stenting and Angioplasty in Patients at High Risk for Endarterectomy; randomized trial comparing endarterectomy to carotid stenting, 800 patients.

·      Principal Investigator, ARCHER Carotid Stent Trial.

·      Principal Investigator, Cleveland Clinic Registry on Carotid Stenting for High Surgical Risk Patients.

·      Co-Principal Investigator, CORAL Renal Study, NIH

·      Principal Investigator, ACT I Stenting versus Endarterectomy Trial, Abbott Vascular Devices.

·      Principal Investigator, Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA), Sanofi and Bristol-Myers Squibb.

·      Principal Investigator, RESIST Renal Artery Stenting Study, Medical College of Ohio

·      Principal Investigator, Multicenter Clinical Evaluation of Carotid Stenting with Protection, Cordis

·      Principal Investigator, Carotid Revascularization with ev3 Arterial Technology Revolution (CREATE), ev3

·      Principal Investigator, Cerebrovascular Interventional Database Registry

·      Principal Investigator, Maveric carotid stent system trial, Medtronic

·      Principal Investigator, ARCHER long term follow up, Guidant

·      Principal Investigator, Carotid Artery Stenting with Emboli Protection Surveillance –                        Post Market Study (CASES-PMS), Cordis

·      Principal Investigator, Post-Market Study of Guidant Carotid Stent Systems and      Embolic Protection Systems (CAPTURE), Guidant

Awards and honors
His scientific and entrepreneurial work has been widely recognized, having received multiple honors including: American Heart Association Top Ten Scientiﬁc Advances, 2003; Ellis Island Medal of Honor, 2004; 50 Best Doctors in the History of the Cleveland Clinic, 2011; Ernst and Young Entrepreneur of the Year (healthcare), 2011; Intel Innovation Award, 2011; his procedure for stroke treatment became a Class I recommendation of the American Heart Association and the American College of Cardiology, 2011; American Heart Association Honoree, 2016.

Patents
Dr. Yadav has been a prolific inventor across a number of disciplines including stent design, emboli prevention devices, cardiac valves, left ventricular assist devices, contrast mediated nephrotoxicity, wireless implants for heart failure, hydrocephalus and surgical navigation.

Personal life
On XX, XXXX, XXXX, Jay Yadav married, Marshalla XXX of XXX. He currently resides in Atlanta Georgia. They have four children, Nevin Yadav of XXX, Chethan Yadav of XXX, Priya Yadav of XXX, Daven Yadav of XXX